Table 1.
Demographics and Clinical Status | Total Sample (n = 219) | ND Interested n = 106 (48%) |
Less ND Interested n = 114 (52%) |
P value |
---|---|---|---|---|
Gender- (Male, N,%) | 123 (56%) | 59 (56%) | 64 (57%) | 0.88 |
Age (Years, Mean, SD) | 54.5 (7.9) | 54.5 (7.3) | 54.5 (8.4) | 0.96 |
Highest Education (N, %) | 42 (19%) | 21 (20%) | 21 (19%) | 0.10 |
High school, GED or less | 103 (47%) | 57 (54%) | 46 (47%) | |
Some college, incl. technical College graduate | 73 (33%) | 57 (26%) | 46 (33%) | |
Ethnicity (N, %) | ||||
White/Non-Hispanic | 149 (68%) | 71 (67%) | 78 (69%) | 0.75 |
Annual Family Income (N, %) | ||||
< $60,000 | 73 (33%) | 34 (34%) | 39 (38%) | 0.63 |
$60,000-80,000 | 60 (27%) | 32 (32%) | 28 (27%) | |
> $80,000 | 68 (31%) | 33 (33%) | 35 (34%) | |
Smoking History- Yes (N, %) | 29 (14%) | 11 (10%) | 15 (13%) | 0.51 |
Years of Diabetes (Mean, SD) | 8.1(6.0) | 7.7(5.2) | 8.5(6.7) | 0.30 |
Glycemic Status | ||||
Mean Hemoglobin A1c | 8.06 (0.79) | 7.97 (0.69) | 8.14 (0.87) | 0.11 |
Medical History (N, %) | ||||
Obesity | 156 (71%) | 72 (68%) | 84 (74%) | 0.50 |
Hyperlipidemia | 96 (43.8%) | 49 (46.2%) | 47 (41.6%) | 0.49 |
Hypertension | 134 (61.2%) | 61 (57.6%) | 73 (64.6%) | 0.29 |
Retinopathy/Cataracts | 49 (22.5%) | 24 (23%) | 25 (22%) | 0.93 |
Nephropathy/Renal Disease | 28 (13%) | 13 (12%) | 15 (13%) | 0.85 |
Neuropathy | 28(13.%) | 13(13%) | 15(13%) | 0.85 |
CVD | 19 (9%) | 11 (10%) | 8 (7%) | 0.39 |
Healthcare Rating | ||||
Overall (Mean, SD) | 7.8 (1.7) | 7.6 (1.8) | 7.9 (1.7) | 0.26 |
For Diabetes (Mean, SD) | 7.6 (1.9) | 7.2 (2.0) | 8.0 (1.9) | 0.005 |
Experience & Knowledge of ND Care | ||||
Seen ND Previously (N, %) | 21 (10%) | 14 (13%) | 7 (6%) | 0.08 |
Seen ND for Diabetes (N, %) | 9 (4%) | 9 (8%) | 0 (0%) | 0.01 |
Previous Knowledge of ND Care (N, %) | 21 (10%) | 15 (14%) | 6 (5%) | 0.03 |
Table 1 details the baseline demographics and clinical characteristics of the entire survey sample and compared by ND Interest subgroups. The reported P-values are for differences in proportions compared between subgroups by chi2 test.